LNP Analytics

Beyond Particle Size: Building a Complete Analytical Strategy for LNPs

Pharma's Almanac

Prevention

Preventive Therapeutics Beyond Vaccines

David Alvaro, Ph.D.

Pharma's Almanac

Vaccine Development

New Vaccine Technologies Expand the Frontiers of Prevention and Treatment

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AOCs

Antibody–Oligonucleotide Conjugates Clinical Manufacturing — A New Paradigm Shift of Bio-Conjugates for Therapeutics

Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.

GBI Biomanufacturing

Thermostable Vaccine

Thermostable Vaccines and the Future of Global Distribution

David Alvaro, Ph.D.

Pharma's Almanac

Asia Manufacturing

APAC Expands Specialized Manufacturing Capabilities Across High-Value Modalities

Pharma's Almanac

Vaccines

The Next Generation of Vaccine Platforms

David Alvaro, Ph.D.

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Roundtable

How is the increasing complexity of modalities reshaping CDMO differentiation and specialization strategies?

Pharma's Almanac

GCE

Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Neuro RNA

Targeting RNA in the Nervous System: The Rise of Antisense and RNA Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

mRNA Vaccine

When Review Stops at the Door: The FDA, mRNA Influenza Vaccines, and the Future of Regulatory Consistency

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

RNA Polymerase

Smarter Polymerases, Cleaner Transcripts, Better RNA

Jing Zhu, Ph.D.

Recipharm Advanced Bio

CRISPR

Integrated Capabilities Enable Faster Development of Effective CRISPR Therapies

Jessica Madigan; Amanda Haas

BIOVECTRA

LNPs

Expanding LNP Applications Beyond mRNA Vaccines

Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano

BioCina

mRNA Therapeutics

mRNA Therapeutics Are Just Getting Started: Charting a Post-Pandemic Path Forward

Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano

BioCina

Biological Design

Foundational Models in Biological Design, Part 3: Translational and Regulatory Outlook

David Alvaro, Ph.D.

Pharma's Almanac

Biological Design

Foundational Models in Biological Design, Part 2: Designing for Manufacturability

David Alvaro, Ph.D.

Pharma's Almanac

Biological Design

Foundational Models in Biological Design, Part 1: Multimodal and Controllable

David Alvaro, Ph.D.

Pharma's Almanac

mRNA–LNP

Integrated mRNA–LNP Manufacturing as a Platform for Innovation

Jan Bekker

BioCina